Related Experiment Video
Updated: Jul 7, 2026
06:29
Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
Published on: March 1, 2011
Clinical Inflammasome Biomarkers: Progress and Prospects
Jared R Coombs1, Sabrina S Burgener1, Kate Schroder1
1Institute for Molecular Bioscience, The University of Queensland, 306 Carmody Road, St Lucia, QLD 4072, Australia.
Journal of Molecular Biology
|July 5, 2026
Summary
Developing specific biomarkers for inflammasome signalling is crucial for advancing chronic disease treatments. This review examines the challenges and opportunities in creating reliable biomarkers for inflammasome activity.
Area of Science:
- Biochemistry
- Immunology
- Molecular Biology
Background:
- Pathological inflammasome signaling drives chronic diseases via low-grade inflammation.
- Subclinical inflammation is difficult to define and measure at the molecular level.
- Inflammasome inhibitors show therapeutic promise but face clinical translation barriers due to a lack of specific biomarkers.
Purpose of the Study:
- To review the trade-offs between specificity and feasibility of inflammasome biomarkers.
- To weigh the opportunities and limitations of proximal and distal biomarkers.
- To highlight the urgent need for novel biomarker strategies for inflammasome signaling.
Main Methods:
- Review of current literature on inflammasome biomarkers.
- Analysis of direct (proximal) and indirect (distal) indicators of inflammasome activity.
- Evaluation of clinical trial biomarker strategies.
Main Results:
- Direct inflammasome biomarkers are experimental and lack standardization.
- Routinely measured inflammation markers are validated but distal and confounded.
- A gap exists between the need for specific inflammasome biomarkers and current clinical feasibility.
Conclusions:
- Novel biomarker strategies are urgently required to accurately reflect inflammasome signaling in humans.
- Balancing biomarker specificity with clinical feasibility is essential for drug development.
- Addressing biomarker challenges will facilitate the clinical translation of inflammasome inhibitors.
Related Concept Videos
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:28Inflammation: Introduction
Inflammation is a fundamental, protective biological response of vascularized tissues to cellular injury, infection, or harmful stimuli. Its primary function is to eliminate the initial cause of injury, clear necrotic cells and damaged tissue, and initiate the necessary repair processes.Cardinal SignsAcute inflammation presents with classic signs. Redness results from vasodilation and increased blood flow. Heat is due to increased metabolism and circulation. Swelling results from the...